Skip Navigation

European Heart Journal 1999 20(20):1485-1492; doi:10.1053/euhj.1999.1628
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hoffmann, R.
Right arrow Articles by Hanrath, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, R.
Right arrow Articles by Hanrath, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Extent and severity of test positivity during dobutamine stress echocardiography. Influence on the predictive value for coronary artery disease

R. Hoffmannf1, H. Lethen, H. Kühl, W. Lepper and P. Hanrath

Medical Clinic I, University Clinic RWTH Aachen, Aachen, Germany

revised March 8, 1999; accepted March 10, 1999

Abstract

Aims Recent studies have evaluated the diagnostic accuracy and predictive value of dobutamine echocardiography without considering the additional information implied by the magnitude of induced wall motion abnormalities. We sought to evaluate the positive predictive value of dobutamine echocardiography for coronary artery disease from the extent and severity of the induced wall motion abnormality. In addition, we intended to determine factors associated with false-negative dobutamine echocardiography.

Methods and Results Two hundred and eighty-three consecutive patients with suspected coronary artery disease underwent dobutamine echocardiography (up to 40µg.kg–1.min–1+atropine up to 1mg) and coronary angiography. The number of segments and the degree of deterioration were used to describe the extent and severity of induced wall motion abnormality. Analysis of clinical, procedural and echocardiographic variables was performed to determine factors associated with false-negative results. The positive predictive value of dobutamine echocardiography increased from 85% to 90%, 94% and 94% with deterioration of wall motion by one grade in ≥1, ≥2, ≥3 and ≥4 segments, respectively (P<0·05). Deterioration of wall motion by two grades in one segment had a positive predictive value of 96% as compared to 85% for deterioration by only one grade in one segment (P<0·05). Patients with false-negative test results received atropine more frequently (28% vs 13%, odds ration [OR]=3·87, 95% confidence interval [CI]=1·54–9·75,P =0·028) than patients with a correct positive result. However, angina (15 vs 37%, OR=0·26, 95% CI=0·09–0·71, P=0·010), ECG changes during dobutamine stress (15% vs 35%, OR=0·49, 95% CI 0·19–1·25,P =0·014) and high image quality (OR 1·59, 95% CI 1·07–2·37,P =0·015) were less frequent. The sensitivity of dobutamine echocardiography increased from 67% to 71% and 86% (P<0·05) with increasing achieved maximal heart rate (<75%, 75–85% and >85% of maximal heart rate).

Conclusion The positive predictive value of dobutamine echocardiography increases significantly as the extent and severity of induced wall motion abnormality increases. Thus, the degree of test positivity should be reported in clinical practice. Despite high pharmacological drug doses, the haemodynamic response may still be insufficient in some patients to induce myocardial ischaemia, resulting in false-negative dobutamine echo tests. To maximize the sensitivity of dobutamine echocardiography, the highest haemodynamic stress level, with a heart rate above 85% of the predicted heart rate, should be reached.

Key Words: Coronary artery disease, dobutamine echocardiography, positive predictive value

f1 Correspondence : Rainer Hoffmann, MD, Medical Clinic I, University Clinic RWTH Aachen, Pauwelsstrasse, 52057 Aachen, Germany


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
C. B. Ingul, E. Rozis, S. A. Slordahl, and T. H. Marwick
Incremental Value of Strain Rate Imaging to Wall Motion Analysis for Prediction of Outcome in Patients Undergoing Dobutamine Stress Echocardiography
Circulation, March 13, 2007; 115(10): 1252 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
I. Ikonomidis, G. Athanassopoulos, J. Lekakis, K. Venetsanou, M. Marinou, K. Stamatelopoulos, D. V. Cokkinos, and P. Nihoyannopoulos
Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study
Circulation, November 22, 2005; 112(21): 3272 - 3279.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. Pellerin and S.J.D. Brecker
A step further in inter-institutional agreement in interpretation of dobutamine stress echocardiograms
Eur. Heart J., May 2, 2002; 23(10): 768 - 771.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.